Source: Circulation. Unidade: FM
Subjects: REVASCULARIZAÇÃO MIOCÁRDICA, DOENÇA AGUDA, INFARTO DO MIOCÁRDIO, COMORBIDADE, CHOQUE CARDIOGÊNICO, FATORES DE RISCO, ISQUEMIA, REVIDIVA
ABNT
KOHLI, Payal et al. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study. Circulation, v. 127, n. 6, p. 673-680, 2013Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.112.124248. Acesso em: 28 maio 2024.APA
Kohli, P., Wallentin, L., Reyes, E., Horrow, J., Husted, S., Angiolillo, D. J., et al. (2013). Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study. Circulation, 127( 6), 673-680. doi:10.1161/CIRCULATIONAHA.112.124248NLM
Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study [Internet]. Circulation. 2013 ; 127( 6): 673-680.[citado 2024 maio 28 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.112.124248Vancouver
Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study [Internet]. Circulation. 2013 ; 127( 6): 673-680.[citado 2024 maio 28 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.112.124248